New Study: States Could Save Up to $1.8 Billion Annually by Prioritizing Lower-Cost Biosimilar Medicines
At a time when states across the country are grappling with significant budget challenges, a new study from the Center for Medical Economics and Innovation at the Pacific Research Institute – the nonpartisan, California-based, free market think tank – finds that state employee health plans could save up to $1.8 billion every year by making greater use of lower-cost biosimilars. Click to download the study, The Biosimilar Savings Opportunity: Prioritizing Biosimilars Will Generate Significant Savings ...
Unauthorized GLP-1 Knockoffs Risk Patient Safety and Future Innovation, New PRI Brief Warns
As federal regulators intensify enforcement against companies selling unauthorized knockoffs of blockbuster weight-loss drugs, a new Pacific Research Institute brief warns that the booming GLP-1 knockoff market is creating patient safety risks while undermining future breakthrough medicines. “GLP-1s are among the most promising medical breakthroughs in decades, helping patients struggling with diabetes, obesity and other chronic illnesses,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation and the brief’s author. “But ...
Trump’s Push for Healthcare Transparency, Starting With Hospital Prices, Can Go Even Further
The Trump administration is making hospital price transparency a centerpiece of its Make America Healthy Again agenda — and it has a chance to go even further toward achieving this goal. Earlier this month, federal regulators warned more than 500 hospitals that they could be violating federal requirements to disclose their prices. The message from the administration was simple. Patients deserve to know what healthcare costs. Yet transparency shouldn’t stop at hospital prices. If the ...
Trending Topics
Studies
